[1]
Rojas Melo, L.J., Ojeda RodrĂ­guez, K.H., Kerguelen Villadiego, A.L. and Parra Prieto, D.A. 2022. Hypophysitis and secondary adrenal insufficiency associated with Pembrolizumab. Revista Colombiana de EndocrinologĂ­a, Diabetes & Metabolismo. 8, 4 (Feb. 2022). DOI:https://doi.org/10.53853/encr.8.4.726.